ArticleClinical & translational immunology2021

Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.

Carmen Alvarez-Fernández et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.